Lifecore Biomedical Inc (LFCR)
7.31
+0.33
(+4.73%)
USD |
NASDAQ |
Nov 22, 16:00
7.29
-0.02
(-0.27%)
After-Hours: 20:00
Lifecore Biomedical Cash from Investing (Quarterly): -3.392M for Aug. 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -3.392M |
| May 31, 2024 | -2.637M |
| February 29, 2024 | -6.251M |
| November 30, 2023 | -3.979M |
| August 31, 2023 | -5.054M |
| May 31, 2023 | -6.168M |
| February 28, 2023 | 5.431M |
| November 30, 2022 | -3.848M |
| August 31, 2022 | -0.226M |
| May 31, 2022 | -18.80M |
| February 28, 2022 | 65.60M |
| November 30, 2021 | -5.097M |
| August 31, 2021 | 38.27M |
| May 31, 2021 | -13.81M |
| February 28, 2021 | -3.976M |
| November 30, 2020 | 5.246M |
| August 31, 2020 | 0.232M |
| May 31, 2020 | -4.566M |
| February 29, 2020 | -3.686M |
| November 30, 2019 | -5.97M |
| August 31, 2019 | -9.666M |
| May 31, 2019 | -4.424M |
| February 28, 2019 | -73.98M |
| November 30, 2018 | -3.953M |
| August 31, 2018 | -14.44M |
| Date | Value |
|---|---|
| May 31, 2018 | -12.84M |
| February 28, 2018 | -11.28M |
| November 30, 2017 | -4.594M |
| August 31, 2017 | -6.869M |
| May 31, 2017 | -16.01M |
| February 28, 2017 | -4.69M |
| November 30, 2016 | -2.602M |
| August 31, 2016 | -2.122M |
| May 31, 2016 | -13.54M |
| February 29, 2016 | -10.92M |
| November 30, 2015 | -12.57M |
| August 31, 2015 | -3.396M |
| May 31, 2015 | -7.16M |
| February 28, 2015 | -2.145M |
| November 30, 2014 | -10.04M |
| August 31, 2014 | -15.10M |
| May 31, 2014 | -4.694M |
| February 28, 2014 | -2.511M |
| November 30, 2013 | -2.039M |
| August 31, 2013 | -4.097M |
| May 31, 2013 | -2.094M |
| February 28, 2013 | -3.089M |
| November 30, 2012 | -2.454M |
| August 31, 2012 | -2.785M |
| May 31, 2012 | -43.21M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-18.80M
Minimum
May 2022
65.60M
Maximum
Feb 2022
1.365M
Average
-3.912M
Median
Cash from Investing (Quarterly) Benchmarks
| AngioDynamics Inc | -2.405M |
| Precision Optics Corp Inc | -0.0281M |
| Sage Therapeutics Inc | 81.05M |
| Outset Medical Inc | 15.88M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.643M |
| Cash from Financing (Quarterly) | 1.093M |
| Free Cash Flow | -8.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1308 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | 1.325M |
| Free Cash Flow Yield | -3.41% |